Journal: Cell Reports
Article Title: A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
doi: 10.1016/j.celrep.2025.115499
Figure Lengend Snippet: Five-fold cross-validation using different combinations of antibody features to predict in vivo protection The analysis was carried out on a sub-set of antibodies for which in vivo data and all seven features considered were available. Mean Spearman’s correlation coefficients over three replicates are shown; error bars indicate SEM. (A) Plot of the ability of individual antibody features to predict in vivo protection. Then, (B) two, (C) three, or (D) four features were combined to determine whether the predictive performance was enhanced. Auth-M and Auth-L indicate neutralization of authentic virus with mNeonGreen and luciferase reporters, respectively. PNV-L and PNV-G indicate neutralization of pseudovirus with luciferase and GFP reporters, respectively. The PNV-G assay tested a single concentration (250 ng/mL), and the other neutralization assays reported IC 50 values determined from eight-point curves. RBD and FL are epitope communities determined from binning with soluble RBD and trimeric full-length spike ectodomain. Affinity is the K D (M) for the D614G full-length ectodomain and ACE-2 block is the percentage blockage in the presence of antibody.
Article Snippet: The abundance of antibodies in the CoVIC allowed finer definition of epitope groups through high-resolution, high-throughput surface plasmon resonance (HT-SPR) epitope binning using the LSA platform (Carterra) with either soluble RBD or full-length spike protein as the antigen.
Techniques: Biomarker Discovery, In Vivo, Neutralization, Virus, Luciferase, Concentration Assay, Blocking Assay